Kevin Choi lost half his vision to glaucoma at the age of 26, which led him to cofound Mediwhale, a healthtech startup that uses AI to detect critical diseases.
Mediwhale's technology primarily focuses on screening for cardiovascular, kidney, and eye diseases through non-invasive retinal scans, helping with faster and early detection of silent killers like heart and kidney diseases.
Choi believes AI can assist healthcare providers in making quicker and smarter decisions in screening, but he emphasizes that AI is not a substitute for doctors who can provide nuanced decision-making beyond data points.
While AI can streamline processes and flag risk levels, doctors are essential in understanding patients' emotional states, behaviors, and guiding complex decision-making processes that go beyond pure data analysis.